Clinical Trial: NRG LU008

NRG LU008

Status: Open

Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer

Eligible for screening study DCP 001

LU008 is reopened to accrual, effective January 7, 2025.